|Application ||WB, IHC-P, E|
|Calculated MW||40529 Da|
|Antigen Region||22-51 aa|
|Other Names||Tyrosine-protein phosphatase non-receptor type 7, Hematopoietic protein-tyrosine phosphatase, HEPTP, Protein-tyrosine phosphatase LC-PTP, PTPN7|
|Target/Specificity||This PTPN7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 22-51 amino acids from human PTPN7.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||PTPN7 Antibody (S44) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Protein phosphatase that acts preferentially on tyrosine-phosphorylated MAPK1. Plays a role in the regulation of T and B-lymphocyte development and signal transduction.|
|Cellular Location||Cytoplasm. Cytoplasm, cytoskeleton|
|Tissue Location||Expressed exclusively in thymus and spleen.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
PTPN7 is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. PTPN7 is preferentially expressed in a variety of hematopoietic cells, and is an early response gene in lymphokine stimulated cells. The noncatalytic N-terminus of this PTP can interact with MAP kinases and suppress the MAP kinase activities. This PTP has been shown to be involved in the regulation of T cell antigen receptor (TCR) signaling, which is thought to function through dephosphorylating the molecules related to MAP kinase pathway.
Eswaran,J., Biochem. J. 395 (3), 483-491 (2006)
Mustelin,T., J. Mol. Biol. 354 (1), 150-163 (2005)
Pettiford,S.M., Leukemia 17 (2), 366-378 (2003)
Kosaki,K., J. Clin. Endocrinol. Metab. 87 (8), 3529-3533 (2002)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.